Day: October 1, 2024

NEW YORK, Oct. 01, 2024 (GLOBE NEWSWIRE) — Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the addition of GPS Marine, a leading provider of marine construction and logistics services, to its growing number of customer accounts. GPS Marine delivers critical maritime services across the UK’s inland waterways and coastal regions. With decades of experience, GPS Marine has established itself as a key player in the maritime industry, providing high-quality, reliable services essential to the smooth operation of vital infrastructure. From large-scale dredging operations that keep waterways navigable to complex marine construction projects that support the growth of ports and harbors, GPS Marine ensures...

The installation includes a combination of C-Bond’s Ballistic-Resistant System, C-Bond Secure, and solar film on multiple floors of the university SAN ANTONIO, Texas, Oct. 01, 2024 (GLOBE NEWSWIRE) — C-Bond Systems (the “Company” or “C-Bond”) (OTC: CBNT), a developer and marketer of glass strengthening solutions for enhanced safety, today announced that its Patriot Glass Solutions subsidiary has been awarded a $400,000 installation at a university in Texas. The installation is a combination of C-Bond BRS (ballistic-resistant system), C-Bond Secure forced entry-resistant film, and solar film at the entrance, ground floors, and upper floors of the building. C-Bond Secure is an application to deter forced entry, and C-Bond BRS is a bullet-resistant film system certified to pass NIJ Level I, Level IIA, Level II, Level III, and Underwriters...

WILMINGTON, Del., Oct. 01, 2024 (GLOBE NEWSWIRE) — InterDigital, Inc. (Nasdaq: IDCC), a mobile, video and AI technology research and development company, today announced that the company has signed new patent license agreements with TPV, a major manufacturer of a range of digital TVs under various brands. These agreements license TPV to InterDigital’s extensive portfolio of HEVC patents as well as DTV patents licensed through InterDigital´s joint licensing program with Sony. “These agreements are another testament of the value of our portfolio in the consumer electronics space,” commented Eeva Hakoranta, Chief Licensing Officer, InterDigital. “InterDigital’s leadership in video technologies such as HEVC showcases how our innovation underpins a broad range of video-based devices and services, and we’re delighted to have closed these...

SOUTH SAN FRANCISCO, Calif., Oct. 01, 2024 (GLOBE NEWSWIRE) — Aligos Therapeutics, Inc. (Nasdaq: ALGS) a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today announced the appointment of David Perry as Vice President of Business Development, effective immediately. “We are pleased to welcome David to the Aligos team during this exciting time for the company,” said Lesley Ann Calhoun, Executive Vice President and Chief Financial Officer at Aligos. “David’s expertise in leading valuable partnerships will be instrumental as we strategically look to maximize the potential of our best-in-class pipeline, including ALG-055009, which recently announced positive topline data.” “I am excited to join Aligos at this critical time in the Company’s growth,...

SAN DIEGO, Oct. 01, 2024 (GLOBE NEWSWIRE) — BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the treatment of solid tumors, today announced acceptance of an abstract for oral presentation at the upcoming Society for Melanoma Research 21st International Congress (SMR), being held from October 10–13, 2024, in New Orleans, LA. Oral Presentation Details:Abstract title: Evalstotug (BA3071): a potent conditionally active biologic (CAB) anti-CTLA-4 antibody designed to enable high exposures, extended dosing, and reduced immune-mediated toxicityPresenting Author: William Boyle, Ph.D.Abstract Type: OralSession Category: Developmental ImmunotherapyDate & Time:  Friday, October 11th, 2024 from 8:00am–10:20am...

Medicare beneficiaries encouraged to evaluate their plan benefits during annual enrollment period, Oct. 15-Dec. 7 ORANGE, Calif., Oct. 01, 2024 (GLOBE NEWSWIRE) — Alignment Health Plan, an award-winning Medicare Advantage (MA) plan from Alignment Health, today announced more than 55 plan benefit options designed to meet seniors’ evolving health care needs. For 2025, Alignment is offering more choices for the growing population of seniors who need specialized care and maintaining consistency in the benefits it offers that holistically address seniors’ overall health and wellness. The plans will be available to 8.1 million Medicare-eligible adults, who can select from Alignment’s portfolio during the Medicare annual enrollment period, which runs Oct. 15 through Dec. 7 for plan benefits starting Jan. 1, 2025.1 “Seniors have an abundance...